🇺🇸 FDA
Patent

US 11572575

Compositions for transfecting resistant cell types

granted A61KA61K47/14A61K47/18

Quick answer

US patent 11572575 (Compositions for transfecting resistant cell types) held by Precision Nanosystems ULC expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Precision Nanosystems ULC
Grant date
Tue Feb 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K47/14, A61K47/18, A61K9/14, A61K9/5123